+381 11 3300 910/

Share

Niš-Based NeoMedica Expands Operations in North Africa, Launches Diagnostic Test Production in Algeria

May 7, 2025

Share

NeoMedica, a domestic innovator in the field of diagnostic tests, has signed a Memorandum of Understanding with a strategic partner in Algeria, marking the official start of a joint venture for local production of “Naissa” tests.

NeoMedica develops and manufactures tests intended for the early detection and monitoring of various diseases, including autoimmune and infectious diseases, hormonal disorders, tumor markers, viruses, and other specific proteins. The tests are used on modern analyzers “Naissa” and “Uni,” both produced at the company’s facility in Niš.

By signing this memorandum, NeoMedica has secured access to the Algerian public healthcare system, which serves a population of 45 million. Local production and technology transfer will ensure a 25% advantage in all tenders, while also reducing the country’s need for importing similar products, in line with the capacity of domestic manufacturing.

“This partnership represents a significant step in NeoMedica’s international expansion strategy. We are proud that our work and products are finding their place in state healthcare systems beyond Serbia, reaffirming their quality and scientific value,” said Saša Tričković, CEO of NeoMedica.

The company’s products have already been successfully present in the Algerian healthcare system for the past two years. Their application has been validated through multiple clinical studies, especially in the field of autoimmune diseases, with results published in leading international scientific journals. Additional research is underway in the areas of tumor markers, gastrointestinal, and hormonal status, involving five more tests from the company’s portfolio.

The official signing of the production agreement is planned for September this year, during a scientific conference organized by NeoMedica in cooperation with its Algerian partners.

At the end of February, NeoMedica launched the production of hematology reagents at its facility in Cairo, Egypt. The upcoming immunochemistry test production in Algeria aims to serve the North African and Middle Eastern markets with high-tech products.

Photo: Saša Tričković

Share

Share

LATEST NEWS

Čadež: Expo 2027 Serbia and Gitex Global Dubai Can Achieve Great Things

Aug 1, 2025

Čadež: Expo 2027 Serbia and Gitex Global Dubai Can Achieve Great Things

From Belgrade to Beijing: Domestic Products, Knowledge, and Quality in the Spotlight

Jul 31, 2025

From Belgrade to Beijing: Domestic Products, Knowledge, and Quality in the Spotlight

Innovative Project of the Serbian Chamber of Commerce Reaches Finals of Prestigious World Chambers Competition (WCF ICC) July 29, 2025

Jul 29, 2025

Innovative Project of the Serbian Chamber of Commerce Reaches Finals of Prestigious World Chambers Competition (WCF ICC) July 29, 2025